Michel KhalafDirector · President & CEO
4
Filed Nov 12, 2026Period of report Nov 10, 20260001535491-26-000007
| Transaction | Security | Shares | Price | ValueValue (shares × price) | Held after | Ownership |
|---|---|---|---|---|---|---|
SaleNov 10, 2026 | Common StockF1F2 | 187,425 | $102.9676 | $19.30M | 759,013 | Direct |
Filing footnotes · 7
- F1The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on November 10, 2026, and related tax obligations and fees.
- F2The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $102.59 to $103.235, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
- F3Includes 3,073 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.
- F4The options became exercisable in three equal installments on February 28, 2018, 2019, and 2020.
- F5The options became exercisable in three installments on March 2, 2019, 2020 and 2021.
- F6The options became exercisable in three installments on February 26, 2020, 2021 and 2022.
- F7The options become exercisable in equal installments on each of the first three anniversaries of the grant date.